Clinical Leader Webinar

  1. The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials 5/9/2025

    Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

  2. Assessing Diversity In Early-Phase Clinical Trials In A Rapidly Changing Regulatory Environment 5/5/2025

    Learn more about structuring early-phase trials to address population variation and the contributing factors to safe drug administration, both of which are essential to a drug development plan.

  3. Illuminating IHC: Right-Sizing Your Validation And Regulatory Strategy 5/2/2025

    In this presentation, expert speakers provide an in-depth exploration of the essential validation and regulatory strategies for Immunohistochemistry (IHC).

  4. Illuminating IHC: From Biomarker To Clinical Trial Assay 5/2/2025

    Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.

  5. Navigating Pediatric Clinical Trials: Challenges And Specific Strategies For Success 5/2/2025

    Advance your understanding of pediatric therapeutics with experts who will help you to navigate the complexities of designing age-specific trials and overcome specimen collection obstacles.

  6. Blueprint For Efficient Clinical Trial Disclosure 4/21/2025

    Explore a comprehensive framework that helps organizations continuously assess and improve their clinical trial disclosure processes.

  7. Accelerating Clinical Data Review With Traceable Workflows 4/17/2025

    Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.

  8. Accelerate Parkinson's Drug Development With Active, Passive DHT Monitoring 4/15/2025

    Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.

  9. Unlocking Continued Revenue And Growth From Established Products 4/14/2025

    Gain insights into how pharmaceutical companies successfully handle post-approval regulatory upkeep for established products, focusing on reducing operational costs and expanding global market access.

  10. Critical Imaging Risks In GLP-1 And Neurology Studies 4/3/2025

    In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.